DC-SIGN/CD209 Antikörper (PE)
-
- Target Alle DC-SIGN/CD209 (CD209) Antikörper anzeigen
- DC-SIGN/CD209 (CD209) (CD209)
-
Reaktivität
- Human
-
Wirt
- Maus
-
Klonalität
- Monoklonal
-
Konjugat
- Dieser DC-SIGN/CD209 Antikörper ist konjugiert mit PE
-
Applikation
- Flow Cytometry (FACS)
- Produktmerkmale
- Purified IgG conjugated to R. Phycoerythrin (RPE)
- Klon
- MR-1
- Isotyp
- IgG1
- Top Product
- Discover our top product CD209 Primärantikörper
-
-
- Applikationshinweise
- Optimal working dilution should be determined by the investigator.
- Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
- Format
- Lyophilized
-
-
Dendritic cell-specific ICAM-3-grabbing nonintegrin expression on M2-polarized and tumor-associated macrophages is macrophage-CSF dependent and enhanced by tumor-derived IL-6 and IL-10." in: Journal of immunology (Baltimore, Md. : 1950), Vol. 186, Issue 4, pp. 2192-200, (2011) (PubMed).
: "DC-SIGN (CD209) expression is IL-4 dependent and is negatively regulated by IFN, TGF-beta, and anti-inflammatory agents." in: Journal of immunology (Baltimore, Md. : 1950), Vol. 168, Issue 6, pp. 2634-43, (2002) (PubMed).
: "An anti-ICAM-2 (CD102) monoclonal antibody induces immune-mediated regressions of transplanted ICAM-2-negative colon carcinomas." in: Cancer research, Vol. 62, Issue 11, pp. 3167-74, (2002) (PubMed).
: "
-
Dendritic cell-specific ICAM-3-grabbing nonintegrin expression on M2-polarized and tumor-associated macrophages is macrophage-CSF dependent and enhanced by tumor-derived IL-6 and IL-10." in: Journal of immunology (Baltimore, Md. : 1950), Vol. 186, Issue 4, pp. 2192-200, (2011) (PubMed).
-
- Target
- DC-SIGN/CD209 (CD209) (CD209)
- Andere Bezeichnung
- CD209 (CD209 Produkte)
- Hintergrund
- Synonyms: DC-SIGN
- Gen-ID
- 30835
- UniProt
- Q9NNX6
-